相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
Maximilian Haist et al.
CANCERS (2021)
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
John D. Klement et al.
CANCERS (2021)
Targeting regulatory T cells for immunotherapy in melanoma
Lili Huang et al.
MOLECULAR BIOMEDICINE (2021)
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles
Nausicaa Clemente et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Osteopontin binds ICOSL promoting tumor metastasis
Davide Raineri et al.
COMMUNICATIONS BIOLOGY (2020)
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
Hannah R. Moorman et al.
CANCERS (2020)
Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy
Zhongnan Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina M. Paluskievicz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor infiltrating lymphocytes: The regulator of melanoma evolution
Mihaela Antohe et al.
ONCOLOGY LETTERS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The role of osteopontin in the progression of solid organ tumour
Hailin Zhao et al.
CELL DEATH & DISEASE (2018)
Survival Mechanisms and Influence Factors of Circulating Tumor Cells
Wen-Chao Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis
Ioanna Giopanou et al.
ONCOIMMUNOLOGY (2017)
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Luigi Mario Castello et al.
MEDIATORS OF INFLAMMATION (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells
K. D. M. Nakamura et al.
TUMOR BIOLOGY (2016)
The role of osteopontin expression in melanoma progression
Timea Kiss et al.
TUMOR BIOLOGY (2015)
Osteopontin Promotes the Invasive Growth of Melanoma Cells by Activating Integrin αvβ3 and Down-Regulating Tetraspanin CD9
Miao Yin et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Emerging roles of regulatory T cells in tumour progression and metastasis
Elizabeth C. Halvorsen et al.
CANCER AND METASTASIS REVIEWS (2014)
Osteopontin Shapes Immunosuppression in the Metastatic Niche
Sabina Sangaletti et al.
CANCER RESEARCH (2014)
B7h Triggering Inhibits the Migration of Tumor Cell Lines
Chiara Dianzani et al.
JOURNAL OF IMMUNOLOGY (2014)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Triggering of B7h by the ICOS Modulates Maturation and Migration of Monocyte-Derived Dendritic Cells
Sergio Occhipinti et al.
JOURNAL OF IMMUNOLOGY (2013)
Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis
Santosh Kumar et al.
PLOS ONE (2013)
ICOS Regulates the Generation and Function of Human CD4+ Treg in a CTLA-4 Dependent Manner
Jian Zheng et al.
PLOS ONE (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
ICOS Mediates the Generation and Function of CD4+CD25+ Foxp3+ Regulatory T Cells Conveying Respiratory Tolerance
Mandy Busse et al.
JOURNAL OF IMMUNOLOGY (2012)
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
Tihui Fu et al.
CANCER RESEARCH (2011)
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Sheng Yao et al.
IMMUNITY (2011)
Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells
Marc Vocanson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Tumor Cell Lines and Polymorphonuclear Cells
Chiara Dianzani et al.
JOURNAL OF IMMUNOLOGY (2010)
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
K Warnatz et al.
BLOOD (2006)
Osteopontin expression correlates with melanoma invasion
YW Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Regulation of immune and autoimmune responses by ICOS-B7h interaction
RI Nurieva
CLINICAL IMMUNOLOGY (2005)
ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement
JL Riley et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
